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Conclusions: CS-MRI and DW-MRI are both useful tools for evaluating patients with MG. The SII is more accurate than the ADC to differentiate TLH and NT from THY (AUROC 1.000 and 0.931, respectively). Furthermore, the ADC is a non invasive parameter that could be used for distinguishing TLH from NT, which is useful in selecting patients for surgery since, for nonthymomatous MG, acceptable rates of complete stable remission after thymectomy are found in TLH but not in NT.
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INTRODUCTION
Myasthenia gravis (MG) is a neurological autoimmune disorder caused by autoantibodies against components of the neuromuscular junction. 1 The thymus is clearly involved in the pathogenesis of seropositive MG and is assumed to be one of the sources of anti-acetylcholine receptors (AChR) specific antibodies that are detectable in about 85% of patients with generalized MG. 1 Indeed, at onset of MG, thymic lymphoid hyperplasia (TLH) can be found in up to 65% of patients, whereas a thymoma (THY) is detected in about 15% of patients. 2 Diagnostic imaging is crucial in order to detect the presence and type of thymic abnormality and for defining the proper management since surgical removal is recommended in all cases of THY.
1,2
Conversely, thymectomy is not always indicated in cases of TLH and should not be performed in cases of atrophic thymus or normal thymus (NT; with normal histological appearance and no germinal centres) since stable remission rates after extended thymectomy are significantly higher in TLH compared to NT or atrophic thymus. 2, 3 Hence, a highly reliable diagnostic imaging technique is needed to correctly differentiate these conditions.
To date, computed tomography (CT) is the imaging modality of choice in evaluating the thymus of patients with new onset of MG, 2 although it has limitations in distinguishing TLH from NT when TLH exhibits normal morphology and size within the limit of normal for a given patient's age, a condition that occurs in 45% of subjects with TLH. 4 In addition, CT cannot differentiate TLH from THY when TLH appears as a focal thymic mass (20% of cases) with soft tissue attenuation and no apparent fat content. 2, 4, 5 Magnetic resonance imaging (MRI) is not usually employed in clinical practice, 2 and limited data are available on chemical-shift MRI from few studies with a small number of MG patients. 6, 7 Chemical-shift imaging is more sensitive than CT for detecting fat in tissue and has been successfully used as quantitative technique, by calculating the signal intensity index (SII), to characterize lipid-poor adrenal adenomas that are indeterminate at CT. 8 Thus, similarly, chemicalshift MRI could be particularly useful in differentiating THY from focal TLH with soft tissue attenuation at CT. Moreover, diffusion-weighted (DW)-MRI could represent another useful tool to differentiate THY from non-thymomatous conditions (TLH and NT) and TLH from NT. 2 Indeed, since DW-MRI reflects cell density and cellular architecture, it has been used in different organs, even in the thorax, for distinguishing benign from malignant lesions by calculating the apparent diffusion coefficient (ADC) that is significantly lower in malignant tumors. [9] [10] [11] Nevertheless, currently, no study evaluated the reliability of DW-MRI in differentiating THY from nonthymomatous conditions (TLH and NT) in MG patients. In addition, at present, no data are reported on the characterization of NT and on its distinction from TLH at DW-MRI, although TLH has typically a higher cellular density at histology compared to NT for the presence of germinal centres with lymphoid follicles and for an increased number of Hassall's corpuscles. 12 Thus, TLH could have lower ADC values than NT and DW-MRI could be helpful in this distinction.
The aim of our study was to prospectively investigate the usefulness of chemical-shift and DW-MRI in patients with generalized MG for distinguishing TLH, NT and THY by using the SII and ADC, with the proposal of the optimal cut-point value for each quantitative parameter, and whether these parameters are influenced by patients' age.
MATERIALS AND METHODS

Patient Population
An institutional review board approved the study, and informed consent was obtained from all subjects. In this prospective observational study conducted from January 2007 through December 2013, all subjects with generalized MG that underwent extended thymectomy or thymomectomy were considered eligible for inclusion. Five subjects were excluded for contraindications to MRI (cardiac pacemaker and claustrophobia, 3 subjects) and patient refusal to enrollment (2 subjects). 
Proof of Diagnosis
The histologic and histopathologic results from surgical specimens were the standard reference for all subjects. For the 64 subjects of group A, a histological confirmation of TLH and NT was obtained through extended thymectomy; hence, 49 cases of TLH and 15 cases of NT were identified. For the 24 patients of group B, the diagnosis was pathologically established by surgical removal (thymomectomy plus extended thymectomy); thus, 15 cases of non-advanced THY (stage I-II, including the patient with THY and TLH) and 9 cases of advanced THY (stage III-IV) were found according to the Masaoka-Koga staging system ( Table 1) . The median time between MRI and surgery was 19 days (range, 1-35 days).
MR Imaging Protocol
All exams were performed using a 1.5T unit (Intera-Achieva, Philips Healthcare, Best, The Netherlands) with the manufacturer's 4-channel phased-array torso coil (Sense XL Torso; Philips Healthcare) for signal reception. MRI was performed to cover the entire chest, from the thoracic inlet to the cardiophrenic angle. at the lipid-water interface between the thymus or the lesion on one hand, and the great vessels or the chest wall on the other. However, we used a left-to-right phase-encoding direction if artifacts were detected within the lesion by using the anterior-to-posterior phase-encoding direction (i.e.
Chemical-shift MRI:
large masses that widely protruded from the left or right side of the mediastinum).
Diffusion-weighted MRI: DW imaging was performed using a single-shot spin-echo echo-planar sequence with the following parameters: 360-500 mm field of view, 116x224 image matrix, 45 echo planar imaging factor, 5 mm slice thickness, 0.5 mm intersection gap, 1600 msec repetition time, 62 msec echo time, 1600 Hz/pixel bandwidth. Four signals were acquired per image with diffusion sensitizing gradients applied in three orthogonal planes (x, y, and z), in order to obtain isotropic diffusion weighting, and b values of 0, 150, 500, and 800 sec/mm 2 . All sequences were performed using a parallel imaging technique acquisition and SENSE (sensitivity encoding) reconstruction with a reduction factor (R) of 2. Fat was suppressed by placing a frequency-selective radiofrequency pulse before the pulse sequence. Chemical-shift MRI: For qualitative assessment, the readers determined whether the decrease in signal intensity of the thymus or the lesion was seen on the opposed-phase images relative to the in- values by eliminating the vascular contribution to the calculated ADC which would lead to an increase of the ADC value. [13] [14] [15] For each patient, all the axial sections that included the lesion or the thymus (from 3 to 32 slices) were identified by using both DW sequences and ADC maps, chemical-shift images, and conventional T2-weighted images with and without fat suppression.
MR Image Analysis
Within each of these sections on the ADC maps, a ROI was defined using an electronic cursor along the circumference of the lesion or thymus, but within the boundaries. The ROI was manually drawn to include only the solid portion of the tissue, taking care to exclude obvious cystic and/or necrotic areas which were identified on the corresponding conventional T2-weighted images. The median ADC was calculated from all the ADC values obtained at each axial section of the tissue for each case and was used for further analyses.
Statistical Analysis
The Shapiro-Wilk test was performed and showed that the data were parametric with normal distribution. Hence, all data concerning SII and ADC levels, according to the defined groups and subgroups, were expressed as mean values ± standard deviations and ranges. Furthermore, they
were also represented using box and whiskers plots. were then compared between groups and subgroups. The differences in SII and ADC levels between groups and subgroups were analyzed using the parametric Student-t test. Logistic regression models were estimated in order to evaluate the ability of SII and ADC levels to discriminate between groups (TLH/NT vs. THY) and between subgroups of group A (TLH vs. NT).
The discrimination abilities were evaluated by the Area Under the Receiver Operating Characteristic (ROC) curve (AUROC) that was used to find the optimal SII and ADC cut-points.
The optimal cut-points were determined according to the Youden Index with computation of sensitivity and specificity. Additional analyses aimed to control for age as a potential confounding factor were performed by including the age in logistic regression models. Furthermore, the correlation between both the quantitative parameters (SII and ADC) with age was evaluated by using the Pearson's correlation coefficients. A p value of less than 0.05 was considered indicative of a statistically significant difference. All statistical analyses were performed with "R" software package (release 3.0.2; The R Foundation for Statistical Computing) .
RESULTS
Reliability of MRI in assessing the correct diagnosis
One out of 87 cases with histological diagnosis of microscopic foci of TLH after extended thymectomy was excluded from the SII and ADC measurements because MRI demonstrated fatty involution of the thymus with no islands of soft tissue attenuation in the anterior mediastinum.
Moreover, one subject was listed in both groups (A and B) because histology demonstrated nonadvanced THY and TLH, an association that was correctly suspected on chemical-shift MRI. Thus, MRI was able to define the correct diagnosis in 98.85% of cases (86 out of 87 subjects) in our cohort of patients with generalized MG that underwent surgery during the enrollment period.
Nevertheless, MRI was able to differentiate perfectly between THY and benign conditions (TLH and NT) in all patients.
Interobserver variability for quantitative and qualitative assessment
For quantitative evaluations, the inter-reader agreement regarding both SII and ADC measurements was excellent with an ICC near to 1. was not necessary to compute a statistical index of concordance.
Quantitative analysis: differences of SII and ADC between groups and subgroups
The mean values ± standard deviations of SII and ADC for the TLH/NT group (group A) and THY group (group B), and for subgroups of each group are reported in (Fig. 1d ).
Quantitative analysis: relationship between SII-ADC and age
We analyzed the correlation between both the quantitative parameters and the age of patients in order to search for potential influences of age on SII and ADC values. 
Qualitative analysis
Chemical-shift MRI: at qualitative analysis, for group A, a homogeneous decrease in signal intensity of the thymus was detected on opposed-phase images relative to in-phase images in 61 out of 63 (96.8%) subjects, namely in all patients of the NT subgroup (age range, 18-49ys), and in all patients but two of the TLH subgroup (age range, 15-71ys) (Fig. 4a) . The two cases with no signal intensity loss visually appreciable on opposed-phase images were a 15-year-old woman and a 23-year-old man (SII of 7.77% and 12.66%, respectively), in which histology proved minimally fatty-infiltrated thymic tissue with many lymphoid follicles (Fig. 5a ). No signal intensity loss was detected on opposed-phase images in any patients in the THY group (Fig. 6a) . In addition, chemical-shift MRI successfully revealed a small rounded THY embedded in TLH in a 39-year-old man (SII of 0.64% with no decrease in signal intensity and 31.79% with signal intensity loss, respectively). 
DISCUSSION
MG is an autoimmune disorder of the neuromuscular junction characterized by muscle weakness, often initially involving the extrinsic ocular muscles and subsequently resulting in generalized MG in two-thirds of patients. 1 The thymus has a role in the pathogenesis of MG that is highlighted by the presence of frequent histological abnormalities in patients with generalized MG, namely TLH and THY, and by the clinical benefit after thymectomy in certain conditions. 16 Diagnostic imaging is crucial in all patients affected by MG for evaluating the presence of an underlying TLH or THY and for distinguishing these two conditions in order to select the proper therapeutic management, because the treatment strategies are different. 2, 16, 17 Indeed, surgery is strongly recommended in patients with THY and represents the mainstay of the curative-intent treatment, since complete resection is the most significant positive prognostic factor, both on disease-free and overall survival. 18 Conversely, in non-thymomatous MG, the primary therapeutic management is based on the use of acetylcholinesterase inhibitors and immunomodulatory agents. years, but in none <10 years, although a microscopic and gradually increasing amount of fat in the normal thymus exists from birth. 20 In addition, a recent report described a case of non-suppressing normal thymus in a 21-year-old woman. 23 Thus, similarly to the normal thymus, cases of nonsuppressing TLH at chemical-shift MRI may also occur in patients with MG, even in early adulthood, as seen in our study. Despite the imperfect reliability of chemical-shift MRI by visual assessment in distinguishing TLH from THY, by using SII for quantitative evaluation, we found no overlap in range of SII values between the two groups (TLH/NT versus THY) and a signal intensity loss of 7.77% or greater for TLH/NT group. In addition, the mean SII was significantly higher in TLH/NT group compared to THY group. Previous studies did not measure the SII in evaluating thymic abnormalities, because they did not use dual-echo single-breath-hold acquisition for chemical-shift imaging. 6, 7 Thus, the in-phase and opposed-phase images were separately obtained at chemical-shift MRI, and the signal intensity of the thymic abnormality (TLH and THY) or normal thymus was compared with that of the paraspinal muscles or chest wall muscles by using the chemical shift ratio (CSR) to assess any drop-out in signal intensity of the thymus between the two images. 6, 7, 20 However, the CSR measurement, which is normalized to the paraspinal musculature, could be affected by age and body mass index, since subjects lose muscle mass as they age and the muscle has more fat interspersed between the muscle fiber bundles in older and/or overweight subjects. 6, 24 For this reason, in the present study, we preferred the use of dual-echo chemical-shift MRI, which does not require any normalization for its calculation, as used in previous studies for differentiating adrenal adenomas from non-adenomas. 8 reported for non-invasive THY in previous studies. 10, 11 This discordance could be related to the "perfusion bias" with a consequent overestimation in ADC measurements of those studies. Indeed, as both the investigators used also the images obtained with b values of 0 s/mm 2 for the ADC computation, the ADC value was determined not only by diffusion (related to cell density and cellular architecture) but also by tissue perfusion. Blood flow may determine significant signal attenuation over the low b-value range (from 0 to 100 s/mm 2 ), which artificially inflates diffusion estimates and thus may be mistakenly attributed to diffusion. 13, [25] [26] [27] [28] In contrast with Abdel Razek, that distinguished Masaoka-Koga stage I disease (non-invasive THY) from higher stages (II-IV, invasive THY), we assessed whether DW-MRI could distinguish stage I-II (non-advanced THY, no neo-adjuvant therapy before surgery required), from stage III-IV (advanced THY, neo-adjuvant treatments needed). 11 Although we found a significantly higher mean ADC in non-advanced THY compared to advanced THY, this finding may have been influenced by the higher percentage of type B3 THY in advanced THY subgroup (56% versus 7% of nonadvanced THY subgroup). Indeed, the lower ADC values generally found in malignant tumors compared to benign conditions are related to a combination of higher cell density, tissue disorganization, and increased extracellular space tortuosity, all contributing to reduced motion of water. 13, 25 On these basis, lower ADC values can be expected in type B3 THY that is typically characterized by a prominent population of medium-sized polygonal epithelial cells and is the only histological type of THY that presents nuclear atypia and prominent nucleoli. 29 This finding is similar to that obtained in a recent study by Benveniste and colleagues that evaluated the ability of
2-[ 18 F]-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET)-CT in
differentiating non-advanced from advanced THY and THY from thymic carcinoma. 30 Although no significant association was observed between higher focal FDG uptake and advanced THY, they found that FDG PET-CT is helpful in distinguishing thymic carcinoma and the more aggressive type B3 THY from the other histological types of THY.
30
Albeit chemical-shift MRI is highly accurate in distinguishing TLH and NT from THY, it is not useful in differentiating TLH from NT. Indeed, in our study, the mean SII was not different between subgroups of group A (TLH and NT). This finding proves that the lipid content of the thymus is not different among TLH and NT in subjects of the same age group. In addition, in MG patients, TLH is morphologically indistinguishable from a NT when it has normal size for a given patient's age and exhibits the typical triangular shape, a condition that occurs in 45% of MG patients with TLH. 4 The distinction between TLH and NT would be beneficial in patients with non-thymomatous MG and anti-AChR antibodies in order to select appropriately patients for surgery. Indeed, in nonthymomatous MG, the clinical efficacy of thymectomy has been questioned because the evidence supporting its use is not clear and has largely been based on single-institution retrospective, observational studies. 3 Currently, although no uniformly accepted guidelines are available, thymectomy is believed to be suitable for patients with generalized MG under 50 years with antiAChR antibodies and TLH, as an option to increase the probability of clinical improvement or complete stable remission. 16 Contrariwise, effectiveness of extended thymectomy is still under discussion in patients with generalized MG and atrophic thymus or histological NT because the results of different studies are controversial, and stable remission rates up to 10 years of follow-up are significantly higher in TLH compared to NT or atrophic thymus in the majority of studies. 3, 4 To date, no study characterized the NT with DW imaging nor evaluated the ability of DW-MRI in differentiating TLH from NT. In the present study, the mean ADC of TLH was significantly lower than that of NT, although overlapped values were found. The lower ADC of TLH is probably related to its higher cellular density compared to NT, even for the presence of lymphoid germinal centres in the thymic medulla. Furthermore, a recent study by Matsui and colleagues demonstrated that the number of Hassall's corpuscles per unit area of the thymic medulla is significantly higher in the thymuses of MG patients with TLH compared to MG patients with NT or THY. 12 This new evidence suggests, once again, a higher cellular density and an increased number of prominent cells in TLH compared to NT that could explain the lower ADC values found in TLH.
Another interesting finding of our research is the positive correlation between the quantitative parameters evaluated (SII and ADC) and age of patients in TLH/NT group. For chemical-shift MRI, it suggests a different amount of fatty tissue within the thymus that increases with age; for DW-MRI, it is related to a gradually decreased cellular density in the thymus while age increases.
Although these results are expected for the normal thymus and explained by the progressive fatty replacement and atrophy of the thymus with age, these findings could reflect for TLH a greater response of the thymus under the associated conditions (mostly autoimmune diseases, as MG) in younger subjects, with a lower amount of fat and an increased cellular density (lymphoid germinal centres and Hassall's corpuscles) within the thymus, compared to elderly patients. The present study has some limitations. First, during the enrolment period, we did not include in our cohort all consecutive patients with onset of generalized MG, but only all consecutive patients that underwent surgical resection of the thymus in order to have histological examination as reference standard of diagnosis for all cases. This did not allow us to accurately assess sensitivity and specificity of MRI for detecting thymic abnormalities because patients with an atrophic thymus at CT and MRI, that were excluded from surgery, were not enrolled. Thus, we may have excluded other patients with microscopic foci of TLH or THY that presented an atrophic thymus at MRI.
However, our primary endpoint was to evaluate the accuracy of MRI in differentiating TLH, NT and THY in patients with detectable thymic abnormalities. Second, we did not evaluate the cell count of a representative tissue block for each case in order to determine the number of cell/mm 2 .
The demonstration of a significant negative correlation between cellularity and ADC in TLH/NT group, with higher ADC values for elderly patients compared to early adulthood, would have confirmed that cellular density in TLH decreases with increasing age. . ** Size is the thickness of the thymus gland measured as the maximum dimension perpendicular to the long axis of each lobe for group A and the maximal diameter of the lesion for group B, measured on transverse images. *** Non-advanced thymoma = Masaoka-Koga stage I-II; advanced thymoma = Masaoka-Koga stage III-IV. § One subject is listed in both groups (final diagnosis of thymic lymphoid hyperplasia and non-advanced thymoma in the same patient after thymomectomy and extended thymectomy). § § Mean size obtained in 63 out of 64 patients (for group A) and in 48 out of 49 patients (for thymic lymphoid hyperplasia subgroup) after excluding one subject with a MRI appearance of complete fatty involution of the thymus (histological finding of microscopic foci of thymic lymphoid hyperplasia after extended thymectomy). signal intensity decrease on opposed-phase images, the degree of fatty infiltration is not sufficient to determine a visually obvious decrease of signal intensity within the soft tissue mass. 
